Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma.
2012
Background
Hodgkin lymphoma (HL) is one of the most frequent lymphoma in the western world. Despite a good overall prognosis, some patients suffer relapsing tumors which are difficult to cure. Over a long period Vitamin D has been shown to be a potential treatment for cancer. Vitamin D acts via the vitamin D receptor, a nuclear receptor, acting as an inducible transcription factor. We aimed to investigate the expression of vitamin D receptor as a possible diagnostic marker and potential therapeutic target in HL as well as in B-cell derived non-Hodgkin lymphoma (B-NHL).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
54
References
14
Citations
NaN
KQI